Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

May 16, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), today provides an update on the comprehensive test and research program of its subsidiary Philips Respironics to assess potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam in specific sleep therapy and ventilator devices under the voluntary June 2021 recall notification/field safety notice .* The risk assessments have now been completed for the CPAP/BiPAP sleep therapy devices under the recall notification/field safety notice* i.e.

Philips provides update on completed set of test results for CPAP/BiPAP sleep therapy devices

May 15, 2023 Across East Africa, India and Latin America, Philips Foundation's social impact investment vehicle supported eight health technology enterprises Through its Knowledge Hub, Philips Foundation shares expertise and insights on delivering improved healthcare services to remote and resource-limited settings In close collaboration with Philips, Philips Foundation and its partners continue to support the people of Ukraine affected by the war Amsterdam, the Netherlands – Philips Foundation , with its mission to provide access to quality healthcare for 100 million people a year by 2030, today announced the publication of its 2022 Annual Report . Philips Foundation and its partners provided quality healthcare access to over 26 million people in underserved communities in 2022.

Philips Foundation 2022 Annual Report: partnering to provide healthcare access to over 26 million people in underserved communities

Amsterdam-based company used special price discounts for distributors and manipulated Chinese procurement processes by influencing state-run hospital officials, regulators said.

Royal Philips to Pay $62 Million to Settle China Bribery Probe

Washington, D.C.--(Newsfile Corp. - May 11, 2023) - The Securities and Exchange Commission today announced that Amsterdam-based Koninklijke Philips N.V.

Dutch Medical Supplier Philips to Pay More Than $62 Million to Settle FCPA Charges

May 11, 2023 Late-breaking data presented from largest-ever randomized controlled multicenter clinical trial on optimizing patient safety during coronary procedures Philips-hosted symposiums and onsite trainings to empower better heart care through integrated imaging, devices, software, informatics and services Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing end-to-end cardiology solutions through the care pathway at the annual meeting for the European Association of Percutaneous Cardiovascular Interventions (EuroPCR, May 16-19, Paris, France) to deliver better heart care for patients with greater efficiency. The Philips cardiology portfolio addresses the need for integrating imaging, devices, software, informatics, and services at each point in the cardiac patient journey.

Philips showcases its latest portfolio of cardiology innovations that deliver clinical confidence and efficiency in treating cardiac disease at EuroPCR 2023

May 10, 2023  The hospital will be equipped with state-of-the-art diagnostic and therapeutic oncology solutions over the next three years, contributing to enhanced patient care Amsterdam, the Netherlands, Stockholm, Sweden, and Madrid, Spain – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, radiation therapy leader Elekta (EKTA-B.ST), and oncology service provider Mercurius Health today announced the signing of a 3-year agreement under which Philips and Elekta will install state-of-the-art diagnostic and therapeutic oncology equipment and associated informatics solutions at Mercurius Health's newly-acquired Robert Janker Klinik cancer center in Bonn, Germany. The investment in Philips and Elekta solutions by Mercurius Health is part of its commitment to establishing a major presence in Germany, following the company's acquisition of Robert Janker Klinik earlier this year.

Mercurius Health equips Robert Janker Klinik with integrated oncology solutions from Philips and Elekta

May 9, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced that today's Annual General Meeting of Shareholders (2023 AGM) has reappointed Abhijit Bhattacharya for a two year's term as member of the Board of Management fulfilling the role of CFO, and reappointed Liz Doherty and David Pyott as members of the Supervisory Board. With these reappointments, the composition of the Supervisory Board committees remains unchanged.

Results of Philips' 2023 Annual General Meeting of Shareholders

May 2, 2023 New cost-effective addition to Philips Image Guided Therapy Mobile C-arm platform brings flat panel imaging and ease-of-use to routine surgery Unique user profiles, application-specific protocols and high range of movement enhance the operating room staff experience and contribute to improved patient outcomes Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 1000 – Zenition 10 , a new addition to the company's Zenition mobile C-arm series. Based on Philips' state-of-the-art flat panel detector technology, Zenition 10 helps to expand patient access to routine surgical care and minimally invasive procedures.

Philips extends company's mobile C-arm portfolio with Zenition 10

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company earned a spot on Forbes' 2023 “America's Best Employers for Diversity” list. This is the fourth time that Philips has appeared in the ranking, which is limited to 500 organizations across the country and just 13 in the Health Care Equipment & Services category. Philips integrates inclusion, belonging, equity and wellbeing into every aspect of the em.

Philips Named to the Forbes Best Employers for Diversity 2023 List

Philips' (PHG) first-quarter results benefit from robust performances by the Diagnosis & Treatment and the Connected Care businesses.

Philips' (PHG) Q1 Earnings Jump Y/Y on Strong Top-Line Growth

VIENNA--(BUSINESS WIRE)-- #ai--Philips is a successor to Nuance's dictation workflow solution for Legal and Professional users in North America.

Speech Processing Solutions: Philips is a Successor to Nuance's Dictation Workflow Solution for Legal and Professional Users in North America

Koninklijke Philips N.V. (PHG) Q1 2023 Earnings Call Transcript.

Koninklijke Philips N.V. (PHG) Q1 2023 Earnings Call Transcript

Royal Philips is facing lawsuits and investigations regarding its ventilators and sleep apnea devices. The company showed improved revenue year over year.

Why Shares of Royal Philips Jumped Monday

Coca-Cola

Markets looked primed for a modest decline at the open. Coca-Cola shares moved higher as the beverage giant used its pricing power to push back against inflationary pressures.

Coca-Cola Saw a Nice Pop, but This Healthcare Stock Was Monday's Big Early Winner

Royal Philips NV on Monday reported a widened net loss for the first quarter of the year after booking a provision on the respironics recall-related economic loss class action in U.S.

Philips posts wider loss after booking provision, says ‘uncertainties' remain

April 24, 2023 First-quarter highlights Group sales increased to EUR 4.2 billion, with 6% comparable sales growth Comparable order intake growth was flat, with double-digit growth in the Diagnosis & Treatment businesses, offset by a decline in the Connected Care businesses Income from operations amounted to a loss of EUR 583 million, mainly due to provisions for accelerated restructuring and an important step in litigation EUR 575 million litigation provision is related to the anticipated resolution of the Respironics recall-related economic loss class action in the US Adjusted EBITA increased to EUR 359 million, or 8.6% of sales, compared to EUR 243 million, or 6.2% of sales, in Q1 2022 Operating cash flow improved to EUR 202 million, compared to an outflow of EUR 227 million in Q1 2022 Simplification of operating model and restructuring plans on track Roy Jakobs, CEO of Royal Philips: “I am encouraged that we delivered a solid start to the year, with sales, profitability and operating cash flow improvements in the quarter, a first step to drive progressive value creation. We are executing on our three priorities to enhance patient safety and quality, strengthen our supply chain reliability, and establish a simplified, more agile operating model.

Philips delivers solid operational performance as supply chain improves and actions to enhance execution start to take effect

Philips (PHG) announces its expansion with MIT IMES, which will help researchers and educators access a new critical care dataset.

Philips (PHG) Drives Healthcare Prospects With Enhanced Dataset

Original artwork created by artists and mothers to depict the paradox of parenting  STAMFORD, Conn. , April 19, 2023 /PRNewswire/ -- Philips Avent, the number one childcare brand recommended by moms worldwide, introduces the Parent's Path Art Collection by Philips Avent, a curation of custom artwork created in partnership with artists who are moms.

Parent's Path Art Collection by Philips Avent Showcases the Uniqueness of Each Parenting Journey

April 18, 2023 Latest clinical data set of 200,000 patients from over 200 hospitals, includes pandemic data for a broader and dependable foundation for machine learning Amsterdam, the Netherlands and Cambridge, MA, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a health technology provider, today announced an expansion of its initiative with the Institute for Medical Engineering and Science (IMES) at the Massachusetts Institute of Technology (MIT) to allow health care researchers access to a new critical care data set to help advance machine learning and artificial intelligence (AI) in healthcare. The updated eICU Collaborative Research Database (eICU-CRD) includes de-identified data of 200,000 critical care patients, including patients who were impacted by COVID-19.

Philips and MIT IMES develop enhanced critical care data set to give researchers and educators access to advance clinical understanding and AI in healthcare

April 18, 2023 Healthcare leaders are heavily investing in AI or plan to do so for both critical decision support and operational efficiency, helping tackle staff shortages Largest global survey of its kind shows healthcare leaders continue to recognize virtual care as key to bringing care closer to patients, wherever they are Amsterdam, the Netherlands, and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its Future Health Index (FHI) 2023 report : Taking healthcare everywhere. Unveiled at HIMSS23 , the eighth annual FHI 2023 global report shows healthcare leaders are increasingly prepared to invest in AI, recognize the opportunity virtual care offers to bring care closer to patients, and acknowledge the importance of building partnerships to improve care.

Philips Future Health Index 2023 global report: healthcare leaders focused on addressing staff shortages, with the support of more AI investments

April 17, 2023 Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted the central role that Enterprise Informatics plays in its efforts to enable care providers to concentrate their limited resources on achieving better outcomes for patients. By providing software and hardware solutions that work together seamlessly across care settings, workflows, and across vendors, the company's solutions showcased at HIMSS23 utilize clinical and operational data to enhance productivity, streamline processes and improve results.

Philips at HIMSS 2023: Enterprise Informatics central to solving productivity, staff and patient experience challenges

I last wrote about Philips about a year ago, calling it a "Buy", and my stake has underperformed for the past 10 months. While there are risks in the business, I believe there to be more of an upside than a further downside in the company.

Philips: A Massive Upside, I Say 'Buy'

Philips (PHG) announces that it has entered into a seven-year agreement with Northwell Health, one of the largest healthcare providers in the state of New York.

Philips (PHG) Inks 7-Year Partnership With Northwell Health

Philips and Northwell Health partner to standardize and future-proof patient monitoring across the enterprise

Philips (PHG) announces Philips Virtual Care Management solutions, which provide a comprehensive approach to telehealth for patients, providers and payers.

News for Royal Philips Stock (PHG)